Mylan received a U.S. Tax Court order to turn over documents to the IRS relating to a controversial licensing deal with Forest Laboratories. Source: Drug Industry Daily

Pharmaceutical executives from the nation’s leading firms are urging Congressional leaders to pass a Republican-led tax reform that would allow companies to pay lower taxes. Source: Drug Industry Daily

A California lawmaker introduced a bill that would prohibit pharmaceutical companies from issuing certain prescription drug discounts or coupons to consumers in the state. Source: Drug Industry Daily

Pfizer is the latest drugmaker to reveal that it received subpoenas requesting information on the company’s relationship with nonprofit organizations that curb the prices of costly drugs through financial assistance…

The EMA’s Committee for Medicinal Products for Human Use recommended approvals for six drugs within the EU to treat a range of conditions from an endocrine disease to nausea. Source: Drug…

Sovereign Pharmaceuticals’ Texas facility received a Form 483 after an inspection in November found numerous problems in the facility, including the building’s construction. Source: Drug Industry Daily

The FDA will have to create a task force to identify regulations to repeal or modify under an executive order signed by President Trump last week. Source: Drug Industry Daily

The U.S. solicitor general and several generics makers have filed U.S. Supreme Court briefs in support of reversing a Federal Circuit ruling that orders sponsors to wait six months after…

China’s Ministry of Human Resources and Social Security has expanded the list of drugs covered by state insurance, adding more than 300 drugs to the catalog since it was last…

The Supreme Court ruled to limit the reach of patent protections on single components of a multicomponent product exported for manufacture abroad, reversing an appellate court decision in a unanimous…